期刊文献+

ACE与醛固酮浓度在房颤消融前后变化及其临床意义 被引量:2

Significance of variations of plasma angiotensin converting enzyme and aldosterone before and after atrial fibrillation catheter radiofrequency ablation
原文传递
导出
摘要 目的观察血管紧张素转换酶(ACE)和醛固酮在房颤导管消融术前、后的变化,探讨其在预测房颤复发的应用价值。方法选择经导管消融术的持续性房颤患者(房颤组)38例,同期选择窦性心律患者38例作为对照组,收集房颤组术前、后,对照组入院第2d血清,测定血清ACE和醛固酮浓度。结果房颤组血清ACE和醛固酮浓度显著高于对照组,经过导管消融术后血清ACE和醛固酮浓度均显著下降,差异有统计学意义(P>0.05)。结论 ACE和醛固酮浓度对于房颤的诊断与评估及在预测导管消融后房颤复发方面有重要的应用价值。 Aim To observe the changes of levles of plasma angiotensin converting enzyme (ACE)and aldosterone before and after atrial fibrillation catheter radiofrequency ablation. Methods There 38 catheter ablation cases were selected as the experimental group and another 38 cases with sinus rhythm as control group. Result Levels of ACE and aldosterone in patients with atrial fibrillation were significantly higher than that of sinus rhythm,levels of ACE and aldosterone were significantly reduced after catheter ablation,showing significant differences (P 0.05). Conclusion Detection of levels of ACE and aldosterone is valuable for diagnosis and predicting of atrial fibrillation recurrence.
出处 《中国热带医学》 CAS 2010年第8期1003-1004,共2页 China Tropical Medicine
关键词 心房颤动 血管紧张素转换酶 醛固酮 Atrial fibrillation Angiotensin converting enzyme(ACE) Adosterone
  • 相关文献

参考文献2

二级参考文献13

  • 1Matsuura A, Yamochi W, Hirata K, et al. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression[J].Hypertension, 1998,32: 89-95.
  • 2Pedersen OD, Bagger H, Kober L,et al. Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction[J]. Circulation, 1999,100: 376-380.
  • 3Madrid AH,Bueno MG,Rebollo Jose MG,et al. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study[J]. Circulation,2002,106: 331-336.
  • 4Danish Li ,Shinagawa K ,Pang Li ,et al. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogswith ventricular tachypacing-induced congestive heart failure[J]. Circulation, 2001,104 : 2608-2614.
  • 5Ausma J, Wijffels M, Thone F, et al. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat [J]. Circulation, 1997,96 : 3157-3163.
  • 6Wijffels MCEF, Kirchhof CJHJ, Dorland R, et al.Atrial fibrillation begets atrial fibrillation: A study in awake chronically in strumented goats [J]. Circulation, 1995,92 : 1954-1968,.
  • 7Kanapuli SP,Kumar A. Molecular cloning of human angiotensinogen cDNA and evidence for the presence of its mRNA in rat heart[J]. Circ Res,1987,6:786-790.
  • 8Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation [J]. Biol Chem,1998,273 : 4883-4891.
  • 9Struthers AD. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart[J]. Card Fai1,1996,7:47-54.
  • 10Weber KT. Pathological hypertrophy and cardiacinterstium:fibrosis and renin-angiotensin-aldosteron esystem[J]. Circulation, 1991,83 : 1849-1851.

共引文献49

同被引文献31

  • 1王茂敬,蔡尚郎.心房颤动患者血清肾素和血管紧张素Ⅱ浓度测定的意义[J].岭南心血管病杂志,2009,15(6):467-469. 被引量:3
  • 2张标,曾晓荣,杨艳,刘智飞,张瑜.心房颤动患者心房肌乙酰胆碱敏感钾通道基因表达变化的研究[J].泸州医学院学报,2004,27(3):192-195. 被引量:2
  • 3魏玲,刘斌,李丽娟,卢国良,侯宗柳,刘绍华,张亚林,张筱军.血管紧张素转换酶基因多态性与房颤心肌纤维化的相关性研究[J].西南国防医药,2007,17(6):704-706. 被引量:2
  • 4Schotten U, Verheule S, Kirchhof P, et al. Pathophysiological mech- anisms of atrial fibrillation : a translational appraisal [ J ]. Physiol Rev,2011,91 ( 1 ) :265 - 325.
  • 5Guo P, Wu C, Masaki T, et al. Subdose of fasudil suppresses myo- cardial fibrosis in aldosterone-salt-treated uninephrectomized rats [J]. Pharmazie,2011,66(9) :716 -719.
  • 6Lallier PL, Ducharme A, Keller PF, et al.' Angiotensin-converting en- zyme inhibition in hypertensive patients is associated with a reduc- tion in the occurrence of atrial fibrillation[ J]. J Am Coil Cardiol, 2004,44( 1 ) :159 - 164.
  • 7Dabrowski R, Borowiec A,Smolis-Bak E,et al. Effect combined spi- ronolactone - 13 blocker-enalapril treatment on occurrence of symp- tomatic atrial fibrillation episodes in patients with a history of parox- ysmal atrial fibrillation ( SPIR - AF study) [ J ]. Am J Cardiol, 2010,106(11) :1609 - 1614.
  • 8Bddt A,Scholl A, Garbade J. ACE - inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibril- lation [ J ]. Basic Res Cardio1,2006,101 ( 3 ) : 261 - 267.
  • 9Hanna IR,Heeke B,Bush H,et al. Lipid-lowering drug use is asso- ciated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction [ J ] Heart Rhythm, 2006,3 (8) :881.
  • 10赵莉芳,顾水明,郑宏超.依那普利对房颤的干预[J].内科理论与实践,2008,3(4):276-278. 被引量:1

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部